November 20, 2023, Sangamo Therapeutics Inc (NASDAQ: SGMO) trading session started at the price of $0.3855, that was 7.88% jump from the session before. During the day, the shares moved up to $0.451 and dropped to $0.382 before settling in for the closing price of $0.38. A 52-week range for SGMO has been $0.29 – $3.76.
During the last 5-year period, the sales growth of Healthcare Sector giant was 32.37%. When this article was written, the company’s average yearly earnings per share was at -9.52%. With a float of $158.30 million, this company’s outstanding shares have now reached $166.79 million.
Let’s determine the extent of company efficiency that accounts for 478 employees. In terms of profitability, gross margin is +89.12, operating margin of -180.85, and the pretax margin is -172.37.
Sangamo Therapeutics Inc (SGMO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sangamo Therapeutics Inc stocks. The insider ownership of Sangamo Therapeutics Inc is 10.74%, while institutional ownership is 58.06%. The most recent insider transaction that took place on Sep 26, was worth 3,000,000. In this transaction 10% Owner of this company sold 6,000,000 shares at a rate of $0.50, taking the stock ownership to the 17,652,466 shares.
Sangamo Therapeutics Inc (SGMO) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted -$0.59 earnings per share (EPS) during the time that was less than consensus figure (set at -$0.32) by -$0.27. This company achieved a net margin of -172.76 while generating a return on equity of -57.37. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.52% per share during the next fiscal year.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
You can see what Sangamo Therapeutics Inc (SGMO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Looking closely at Sangamo Therapeutics Inc (NASDAQ: SGMO), its last 5-days average volume was 2.59 million, which is a jump from its year-to-date volume of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 56.63%. Additionally, its Average True Range was 0.06.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 8.99%, which indicates a significant decrease from 33.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 154.25% in the past 14 days, which was higher than the 105.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5721, while its 200-day Moving Average is $1.3357. However, in the short run, Sangamo Therapeutics Inc’s stock first resistance to watch stands at $0.4500. Second resistance stands at $0.4850. The third major resistance level sits at $0.5190. If the price goes on to break the first support level at $0.3810, it is likely to go to the next support level at $0.3470. Should the price break the second support level, the third support level stands at $0.3120.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
There are 177,347K outstanding shares of the company, which has a market capitalization of 73.60 million. As of now, sales total 111,300 K while income totals -192,280 K. Its latest quarter income was 9,400 K while its last quarter net income were -104,160 K.